Developing Prognostic Systems of Cancer Patients by Ensemble Clustering

Table 1

Lung cancer data of 90,214 patients. Survival time is measured in months. Here, adeno, squamous, large, and small represent adenocarcinoma, squamous cell carcinoma, large cell carcinoma, and small cell carcinoma, respectively.

Patient	Survival time (𝑋)	Stage (𝑋1)	Grade (𝑋2)	Histology (𝑋3)	Gender (𝑋4)
1	64	1	2	squamous	1
2	24	1	3	large	1
3	24	2	3	squamous	1
4	8	1	2	squamous	1
5	16	3	3	squamous	2
6	143	3	2	adeno	2
7	6	3	3	small	2
8	1	4	4	small	1
9	9	1	3	adeno	2
—	—	—	—	—	—
—	—	—	—	—	—
90211	1	1	3	squamous	1
90212	2	1	2	adeno	1
90213	62	2	3	adeno	1
90214	4	4	4	squamous	2